Rapp Jonathan H, Yuen Meggie, Abraham Teena
Clinical Pharmacist.
Clinical Pharmacy Coordinator.
Hosp Pharm. 2015 Nov;50(10):918-921. doi: 10.1310/hpj5010-918. Epub 2015 Nov 19.
There have been 3 published reports (4 cases) of symptomatic sinus bradycardia occurring after intravenous (IV) administration of the selective 5-hydroxytryptamine 3 (5-HT) receptor antagonist ondansetron. We report a fifth case in which the patient developed asystole after rechallenge with ondansetron.
A 36-year-old pregnant patient with no cardiac history, status post cerclage for cervical insufficiency, experienced nausea in the post ambulatory care unit after administration of morphine and indomethacin for pain. After IV administration of ondansetron, the patient's heart rate decreased to the 40s and improved spontaneously. The patient experienced a second episode of nausea, another dose of ondansetron was administered, and the patient went into asystole. Advanced cardiac life support measures were initiated and chest compressions were conducted for 3 minutes with return of spontaneous circulation. The patient was monitored overnight with no development of new cardiac arrhythmias and was discharged from the hospital in stable condition.
Sinus bradycardia after IV administration of ondansetron was observed in a 36-year-old pregnant patient status post cerclage. On rechallenge, the patient went into asystole. This case report adds to the available literature regarding ondansetron-induced cardiac arrhythmias and the possibility of asystole upon rechallenge.
已有3篇发表的报告(4例)记载了静脉注射选择性5-羟色胺3(5-HT)受体拮抗剂昂丹司琼后出现症状性窦性心动过缓的情况。我们报告第5例,该患者在再次使用昂丹司琼后发生心脏停搏。
一名36岁无心脏病史的孕妇,因宫颈机能不全行宫颈环扎术后,在门诊护理单元接受吗啡和吲哚美辛止痛治疗后出现恶心。静脉注射昂丹司琼后,患者心率降至40多次/分钟,随后自行改善。患者再次出现恶心,又给予一剂昂丹司琼后,进入心脏停搏状态。启动了高级心脏生命支持措施,进行了3分钟胸外按压,随后恢复自主循环。患者接受了一夜监测,未出现新的心律失常,出院时情况稳定。
在一名36岁宫颈环扎术后的孕妇中观察到静脉注射昂丹司琼后出现窦性心动过缓。再次用药时,患者发生心脏停搏。本病例报告补充了有关昂丹司琼诱发心律失常及再次用药时发生心脏停搏可能性的现有文献。